Connect
MJA
MJA

Middle lobe syndrome as the pulmonary manifestation of primary Sjögren's syndrome

Horng-An Chen, Shinn-Liang Lai, Wei-Kang Kwang, Juhn-Cherng Liu, Chun-Hsiung Chen and De-Feng Huang
Med J Aust 2006; 184 (6): 294-295.

Middle lobe syndrome — recurrent atelectasis and/or bronchiectasis involving the right middle lobe and/or lingula — has, up to now, not been reported as the pulmonary manifestation of primary Sjögren’s syndrome. We describe a patient in whom lymphocytic bronchiolitis in the atelectatic lobes was proved histologically from two separate transbronchial biopsies. The atelectasis responded well to glucocorticoid treatment, suggesting that the peribronchiolar lymphocytic infiltrates may have played an important role in the development of middle lobe syndrome in this patient.

A 53-year-old woman was admitted to our hospital in 2003 with symptoms, for the past 3 days, of shortness of breath, cough, and blood-tinged sputum. Primary Sjögren’s syndrome had been diagnosed in 2002, based on the presence of xerostomia, keratoconjunctivitis sicca, anti-Ro/La antibody, and rheumatoid factor, as well as a positive Schirmer’s test and the results of sialoscintigraphy.

Please login with your free MJA account to view this article in full

  • Horng-An Chen1
  • Shinn-Liang Lai2
  • Wei-Kang Kwang3
  • Juhn-Cherng Liu4
  • Chun-Hsiung Chen5
  • De-Feng Huang6

  • Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan.

Correspondence: 

Competing interests:

None identified.

  • 1. Kwon KY, Myers JL, Swensen SJ, et al. Middle lobe syndrome: a clinicopathological study of 21 patients. Hum Path 1995; 26: 302-307.
  • 2. Ayed AK. Resection of the right middle lobe and lingula in children for middle lobe/lingula syndrome. Chest 2004; 125: 38-42.
  • 3. Rosenbloom SA, Ravin CE, Putman CE, et al. Peripheral middle lobe syndrome. Radiology 1983; 149: 17-21.
  • 4. Nishizaka Y, Oda Y. A case of systemic lupus erythematosus associated with Sjögren’s syndrome diagnosed by lung localization. Nihon Kyobu Shikkan Gakkai Zasshi 1992; 30: 689-694.
  • 5. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
  • 6. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren’s syndrome. Clin Chest Med 1998; 19: 687-699.
  • 7. Deheinzelin D, Capelozzi VL, Kairalla RA, et al. Interstitial lung disease in primary Sjögren’s syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996; 154: 794-799.
  • 8. Papiris SA, Maniati M, Constantopoulos SH, et al. Lung involvement in primary Sjögren’s syndrome is mainly related to small airway disease. Ann Rheum Dis 1999; 58: 61-64.
  • 9. Mathieu A, Cauli A, Pala R, et al. Tracheo-bronchial mucociliary clearance in patients with primary and secondary Sjögren’s syndrome. Scand J Rheumatol 1995; 24: 300-304.
  • 10. Hatron PY, Wallaert B, Gosset D, et al. Subclinical lung inflammation in primary Sjögren’s syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum 1987; 30: 1226-1231.
  • 11. Gardiner P, Ward C, Allison A, et al. Pleuropulmonary abnormalities in primary Sjögren’s syndrome. J Rheumatol 1993; 20: 831-837.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.